Beta-thalassemia (Q21202886)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Beta-thalassemia	scientific article

Statements

scholarly article

0 references

1 reference

22 April 2019

Beta-thalassemia (English)

0 references

beta thalassemia

1 reference

22 April 2019

Raffaella Origa

object named as

Raffaella Origa

2

author given names

Raffaella

author last names

Origa

1 reference

Dimensions Publication ID

18 August 2022

author name string

Renzo Galanello

1

author given names

Renzo

author last names

Galanello

1 reference

Dimensions Publication ID

18 August 2022

language of work or name

0 references

publication date

21 May 2010

1 reference

22 April 2019

Orphanet Journal of Rare Diseases

1 reference

22 April 2019

5

0 references

11

0 references

1

0 references

copyright license

Creative Commons Attribution 2.0 Generic

1 reference

Europe PubMed Central

22 April 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1750-1172-5-11

0 references

Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

19 March 2017

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

19 March 2017

Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

19 March 2017

Pregnancy and beta-thalassemia: an Italian multicenter experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Association of α globin gene quadruplication and heterozygous β thalassemia in patients with thalassemia intermedia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Thalassemia and hypercoagulability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Bisphosphonates in the treatment of thalassemia-associated osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Cord blood stem cell transplantation for haemoglobinopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Modern treatment of thalassaemia intermedia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Update on fertility in thalassaemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Survival and complications in thalassemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Changing patterns of thalassemia worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Recent advances in fetal nucleic acids in maternal plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Stem cell transplantation for hemoglobinopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Growth and puberty and its management in thalassaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Prenatal diagnosis and screening of the haemoglobinopathies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

The population genetics of the haemoglobinopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Dominant beta thalassaemia: molecular basis and pathophysiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

12 September 2017

Liver iron concentrations and urinary hepcidin in beta-thalassemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

27 September 2017

Fetal HLA typing in beta thalassaemia: implications for haemopoietic stem-cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

27 September 2017

Results of long-term iron-chelating therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

27 September 2017

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

Basal and stimulated levels of growth hormone, insulin-like growth factor-I (IGF-I), IGF-I binding and IGF-binding proteins in beta-thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

Mutations in the general transcription factor TFIIH result in beta-thalassaemia in individuals with trichothiodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

Hepatic iron concentration and total body iron stores in thalassemia major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

Final height and endocrine function in thalassaemia intermedia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

Clinical experience using the Androderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

Relationship between genotype and phenotype. Thalassemia intermedia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

β° Thalassemia Trait in Sardinia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

30 May 2018

Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Cholelithiasis in thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Glutathione S-transferase gene polymorphism and cardiac iron overload in thalassaemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Identification of nucleated red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Effects of acarbose in patients with beta-thalassaemia major and abnormal glucose homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Reversal of heart failure in thalassemia major by combined chelation therapy: a case report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Complications of beta-thalassemia major in North America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Hepatocellular carcinoma in the thalassaemia syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Thalassemia minor, the Gilbert mutation, and the risk of gallstones.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Rapid screening of multiple beta-globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893117

29 November 2018

Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in hepatic iron concentration measurement from needle-biopsy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of combined deferiprone and desferrioxamine iron chelating therapy in beta-thalassemia major end-stage heart failure: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined therapy with deferiprone and desferrioxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined therapy with deferiprone and desferrioxamine in thalassemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for death in patients with beta-thalassemia major: results of a case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of hemochromatosis mutations on iron overload of thalassemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined oral and parenteral iron chelation in beta thalassaemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily oral deferasirox for the treatment of transfusional iron overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/20492708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells

1 reference

https://api.crossref.org/works/10.1186%2F1750-1172-5-11

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1186/1750-1172-5-11

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

release_5zxh7elfenep7lwbcvbdhpb37a

1 reference

https://api.fatcat.wiki/v0/release/5zxh7elfenep7lwbcvbdhpb37a

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21202886&oldid=1839241558"